Hillstar Bio | $67,000,000 | (Apr 2, 2025)
Sympera AI | $10,000,000 | (Apr 2, 2025)
LTV.ai | $5,200,000 | (Apr 2, 2025)
Receptor Life Sciences, Inc.
United States
- Seattle, Washington
- 07/04/2022
- Series A
- $9,700,000
Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications.
The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism.
More information is at www.ReceptorLife.com.
- Industry Pharmaceutical Manufacturing
- Website https://receptorlife.com/
- LinkedIn https://www.linkedin.com/company/receptor-life-sciences-inc./
Related People
Mark TheeuwesFounder
United States -
Greater Philadelphia
Experienced Pharmaceutical Executive with a demonstrated history of working in all aspects of Clinical and Commercial Execution.
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
InfiniLink | $10,000,000 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)
EVident Battery, Inc. | $3,200,000 | (Apr 2, 2025)
Notable Systems | $12,000,000 | (Apr 2, 2025)
LightSource | $33,000,000 | (Apr 2, 2025)
Atomic(US) | $10,000,000 | (Apr 2, 2025)
ControlTheory | $5,000,000 | (Apr 2, 2025)